Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1441 AL 1455

The Amyloid Phenomenon and Its Links with Human Disease

Dobson CM.

Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):a023648. doi: 10.1101/cshperspect.a023648.

The thalamus as a relay station and gatekeeper: relevance to brain disorders

Moustafa AA, McMullan RD, Rostron B, Hewedi DH, Haladjian HH.

Rev Neurosci. 2017 Feb 1;28(2):203-218. doi: 10.1515/revneuro-2016-0067.

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

Future Directions in Imaging Neurodegeneration

Masdeu JC.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):9. doi: 10.1007/s11910-017-0718-1.

Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes

Wang Q, Li WX, Dai SX, Guo YC, Han FF, Zheng JJ, Li GH, Huang JF.

J Alzheimers Dis. 2017;56(4):1525-1539. doi: 10.3233/JAD-161032.

[Rapidly progressive dementia and parkinsonism associated to multiple dural arteriovenous fistulas]

Mejia P, Piedra LM, Merchan-Del Hierro X.

Rev Neurol. 2017 Mar 1;64(5):214-218.

MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease

Reddy PH, Williams J, Smith F, Bhatti JS, Kumar S, Vijayan M, Kandimalla R, Kuruva CS, Wang R, Manczak M, Yin X, Reddy AP.

Prog Mol Biol Transl Sci. 2017;146:127-171. doi: 10.1016/bs.pmbts.2016.12.009. Epub 2017 Feb 2.

Cognitive decline in Parkinson disease

Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C.

Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3.

Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases

McKenzie JA, Spielman LJ, Pointer CB, Lowry JR, Bajwa E, Lee CW, Klegeris A.

Curr Aging Sci. 2017;10(3):158-176. doi: 10.2174/1874609810666170315113244.

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Ganguly G, Chakrabarti S, Chatterjee U, Saso L.

Drug Des Devel Ther. 2017 Mar 16;11:797-810. doi: 10.2147/DDDT.S130514. eCollection 2017.

In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes

Umeno A, Biju V, Yoshida Y.

Free Radic Res. 2017 Apr;51(4):413-427. doi: 10.1080/10715762.2017.1315114. Epub 2017 Apr 25.

Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments

Zhao H, Alam A, San CY, Eguchi S, Chen Q, Lian Q, Ma D.

Brain Res. 2017 Jun 15;1665:1-21. doi: 10.1016/j.brainres.2017.03.029. Epub 2017 Apr 7.

Oxidative Stress: Love and Hate History in Central Nervous System

Ortiz GG, Pacheco Moisés FP, Mireles-Ramírez M, Flores-Alvarado LJ, González-Usigli H, Sánchez-González VJ, Sánchez-López AL, Sánchez-Romero L, Díaz-Barba EI, Santoscoy-Gutiérrez JF, Rivero-Moragrega P.

Adv Protein Chem Struct Biol. 2017;108:1-31. doi: 10.1016/bs.apcsb.2017.01.003. Epub 2017 Mar 7.

[Clinical and neuropathological characteristics of dementia with Lewy bodies]

Bencze J, Simon V, Bereczki E, Majer R, Varkoly G, Murnyák B, Kálmán J, Hortobágyi T.

Orv Hetil. 2017 Apr;158(17):643-652. doi: 10.1556/650.2017.30735.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias